@inproceedings{oai:repo.qst.go.jp:00053265,
 author = {Kamada, Tadashi and Tsujii, Hirohiko and Tsuji, Hiroshi and Yanagi, Takeshi and Imai, Reiko and Mizoe, Junetsu and Miyamoto, Tadaaki and Katou, Hirotoshi and Yamada, Shigeru and Katou, Shingo and Yoshikawa, Kyosan and Kandatsu, Susumu and 鎌田 正 and 辻井 博彦 and 辻 比呂志 and 柳 剛 and 今井 礼子 and 溝江 純悦 and 宮本 忠昭 and 加藤 博敏 and 山田 滋 and 加藤 眞吾 and 吉川 京燦 and 神立 進},
 book = {Application of Accelerators in Research and Industry : 17th International Conference on the Application of Accelerators in Research and Industry, Denton, Texas, 12-16 Nov. 2002(AIP Coference Proceedings vol.680)},
 month = {Dec},
 note = {The Heaby Inon Medical Accelerator in chiba(HIMAC)is the world's first heavy ion accelerator complex decided to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing ability. In june 1994, clinical research for the treatment of cancer was begun using carbon ions generated by HIMAC. Until August 2002, a total of 1,297 patients were enrolled in clinical trials. Most of the patients had locally advanced and/or medically inoperable tumors.Tumors radio-resistant and/or located near critical organs were also included. The clinical trials revealed that carbon ion radiotherapy ptovided definite local control and offered a survival advantege without unacceptable morbidity in a variety of tumors that were hard tu cure by other modalities.},
 pages = {1142--1145},
 publisher = {American Institute of Physics},
 title = {Benefit of Carbon Ion Radiotherapy in the Treatment of Radio-resistant Tumors},
 year = {2002}
}